BELLEVUE ASSET MANAGEMENT, LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 247 filers reported holding MIRATI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.

Quarter-by-quarter ownership
BELLEVUE ASSET MANAGEMENT, LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,0000.0%150.0%0.00%0.0%
Q2 2022$1,0000.0%150.0%0.00%0.0%
Q1 2022$1,000
-66.7%
15
-16.7%
0.00%
-50.0%
Q4 2021$3,0000.0%18
-5.3%
0.00%0.0%
Q3 2021$3,0000.0%190.0%0.00%0.0%
Q2 2021$3,000
+50.0%
19
+72.7%
0.00%
+100.0%
Q1 2021$2,000110.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders